lobbying_activities: 2272178
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2272178 | 434d1915-4852-4073-8a74-c4e566e7aa54 | Q1 | FTI GOVERNMENT AFFAIRS | 401054971 | PERRIGO, INC. | 2019 | first_quarter | PHA | Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines. FDA's proposed changes to generic drug labeling. "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", H.R. 5333. "Over-the-Counter Drug Safety, Innovation, and Reform Act", S. 2315. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-18T12:04:44.317000-04:00 |